Tumor Biology

, Volume 35, Issue 9, pp 8439–8443 | Cite as

The effect of TLX3 expression on the prognosis of pediatric T cell acute lymphocytic leukemia—a systematic review

  • Jiexian Ma
  • Jinsheng Hua
  • Yinghao Sha
  • Yanhui Xie


Whether TLX3 is a predictor of prognosis of pediatric T cell acute lymphocytic leukemia (T-ALL) is controversial, with some studies concluding that it is and others concluding the opposite. Therefore, a systematic review was performed to explore the relationship of TLX3 expression with the prognosis of pediatric T-ALL. The PubMed database, The Cochrane Library, conference proceedings, EMBASE databases, and references of published trials and review articles were searched. Two reviewers independently assessed the quality of the trials and extracted data. Hazard ratios (HRs) for disease-free survival (DFS) and odds ratios (OR) for 5-year DFS were pooled using the STATA package. Ultimately, six trials involving 515 patients with pediatric T-ALL were analyzed. The pooled HR (1.07 [0.32, 3.56], p = 0.91) for DFS and OR (1.30 [0.52, 3.27], p = 0.57) for 5-year DFS showed that the TLX3-positive group showed no statistically significant difference with the TLX3-negative group. Our results suggested that TLX3 expression is not an indicator for the prognosis of pediatric T-ALL.


TLX3 Pediatric T-ALL Disease-free survival 


Conflicts of interest



  1. 1.
    Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030–43.CrossRefPubMedGoogle Scholar
  2. 2.
    Amylon MD, Shuster J, Pullen J, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia. 1999;13:335–42.CrossRefPubMedGoogle Scholar
  3. 3.
    Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90 % event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95:416–21.PubMedGoogle Scholar
  4. 4.
    Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350:1535–48.CrossRefPubMedGoogle Scholar
  5. 5.
    Raimondi SC. Cytogenetics of acute leukemias. In: Pui CH, editor. Childhood leukemias. Cambridge: Press Syndicate of the University of Cambridge; 1999. p. 168–96.Google Scholar
  6. 6.
    Rubnitz JE, Look AT. Molecular genetics of acute lymphoblastic leukemia. In: Pui C-H, editor. Childhood leukemias. Cambridge: Press Syndicate of the University of Cambridge; 1999. p. 197–218.Google Scholar
  7. 7.
    Cauwelier B, Dastugue N, Cools J, Poppe B, Herens C, De Paepe A, et al. Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRβ locus rearrangements and putative new T-cell oncogenes. Leukemia. 2006;20:1238–44.CrossRefPubMedGoogle Scholar
  8. 8.
    Asnafi V, Radford-Weiss I, Dastugue N, Bayle C, Leboeuf D, Charrin C, et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage. Blood. 2003;102:1000–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Bernard OA, Busson-LeConiat M, Ballerini P, et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the TLX3 gene in T acute lymphoblastic leukemia. Leukemia. 2001;15:1495–504.CrossRefPubMedGoogle Scholar
  10. 10.
    Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75–87.CrossRefPubMedGoogle Scholar
  11. 11.
    Cave H, Suciu S, Preudhomme C, et al. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood. 2004;103:442–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Ballerini P, Blaise A, Busson-LeConiat M, et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood. 2002;100:991–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Dear TN, Sanchez-Garcia I, Rabbitts TH. The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes. Proc Natl Acad Sci U S A. 1993;90:4431–5.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Mauvieux L, Leymarie V, Helias C, et al. High incidence of Hox11L2 expression in children with T-ALL. Leukemia. 2002;16:2417–22.CrossRefPubMedGoogle Scholar
  15. 15.
    Gottardo NG, Jacoby PA, Sather HN, Reaman GH, Baker DL, Kees UR. Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukemia treated on Children’s Cancer Group protocols. Leukemia. 2005;19:1705–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints. Stat Med. 1998;17:2815–34.CrossRefPubMedGoogle Scholar
  17. 17.
    Chen B, Wang Y-Y, Shen Y. Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries. Leukemia. 2012;26:1608–16.CrossRefPubMedGoogle Scholar
  18. 18.
    Berger R, Dastugue N, Busson M, et al. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH). Leukemia. 2003;17(9):1851–7.CrossRefPubMedGoogle Scholar
  19. 19.
    van Grotel M, Meijerink JPP, van Wering ER. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia. 2008;22:124–31.CrossRefPubMedGoogle Scholar
  20. 20.
    van Grotel M, Meijerink JPP, Beverloo HB. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica. 2006;91:1212–21.PubMedGoogle Scholar
  21. 21.
    Ballerini P, Landman-Parker J, Cayuela JM. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome. Haematologica. 2008;93:1658–65.CrossRefPubMedGoogle Scholar
  22. 22.
    Attarbaschi A, Pisecker M, Inthal A, et al. Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements. Br J Haematol. 2010;148(2):293–300.CrossRefPubMedGoogle Scholar
  23. 23.
    Little J, Bradley L, Bray MS, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease association. Am J Epidemiol. 2002;156:300–10.CrossRefPubMedGoogle Scholar
  24. 24.
    Heerema NA, Sather HN, Sensel MG, Kraft P, Nachman JB, Steinherz PG, et al. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children’s Cancer Group. JCO. 1998;16:1270–8.Google Scholar
  25. 25.
    Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH, et al. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukemia. Lancet. 2004;363:535–6.CrossRefPubMedGoogle Scholar
  26. 26.
    Kees UR, Heerema NA, Kumar R, Watt PM, Baker DL, La MK, et al. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children’s Cancer Group (CCG). Leukemia. 2003;17:887–93.CrossRefPubMedGoogle Scholar
  27. 27.
    Lohmueller KE, Pearce CL, Pike M, et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33:177–82.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Jiexian Ma
    • 1
  • Jinsheng Hua
    • 2
  • Yinghao Sha
    • 1
  • Yanhui Xie
    • 1
  1. 1.Department of HematologyHuadong Hospital Affiliated to Fudan UniversityShanghaiChina
  2. 2.Department of HematologyTaizhou Municipal Hospital Affiliated to Taizhou University Medical SchoolZhejiangChina

Personalised recommendations